Stifel Nicolaus Raises Knight Therapeutics (TSE:GUD) Price Target to C$7.45
Knight Therapeutics (TSE:GUD – Get Free Report) had its target price boosted by Stifel Nicolaus from C$6.25 to C$7.45 in a research report issued to clients and investors on Tuesday,BayStreet.CA reports. The brokerage presently has a “buy” rating on the stock. Stifel Nicolaus’ price objective would suggest a potential upside of 23.34% from the company’s […]
Knight Therapeutics (TSE:GUD – Get Free Report) had its target price boosted by Stifel Nicolaus from C$6.25 to C$7.45 in a research report issued to clients and investors on Tuesday,BayStreet.CA reports. The brokerage presently has a “buy” rating on the stock. Stifel Nicolaus’ price objective would suggest a potential upside of 23.34% from the company’s […]
